Speak directly to the analyst to clarify any post sales queries you may have.
Next-generation sequencing informatics is redefining data management and decision-making in healthcare and life sciences, equipping senior leaders with the digital tools necessary for secure, efficient genomic operations. As technology and compliance standards evolve, organizations require robust informatics platforms to maximize research value, streamline diagnostics, and sustain competitiveness.
Market Snapshot: Next-Generation Sequencing Informatics Market
The next-generation sequencing informatics market continues to experience strong momentum, with a valuation of USD 1.69 billion in 2024 and an anticipated increase to USD 1.99 billion by 2025. With a projected compound annual growth rate of 17.84%, the sector is set to reach USD 6.28 billion by 2032. Growth is fueled by ongoing investments from biotechnology, pharmaceutical, and clinical organizations seeking to adopt innovative informatics tools. Market demand is being defined by the need for digital platforms capable of processing high-throughput sequencing data, supporting regulatory compliance, and optimizing operations across global research and clinical environments. Informatics infrastructure is playing a foundational role in modernizing workflows and creating seamless connections among research institutions and care providers worldwide.
Scope & Segmentation of the Next-Generation Sequencing Informatics Market
- Application Areas: Solutions provide value in oncology research, genetic disorder analysis, infectious disease surveillance, and reproductive health programs. Informatics platforms support diagnostics, tumor profiling, pathogen detection, and prenatal testing for both clinical and research use cases.
- Component Types: Organizations rely on bioinformatics services, subscription-based platforms, analytics modules, and data visualization tools to manage and interpret diverse, large-scale multi-omics datasets for meaningful insights.
- End Users: Key stakeholders encompass research institutes, contract research organizations, diagnostic laboratories, hospitals, pharmaceutical companies, and biotech startups. These users depend on informatics systems to enhance data accuracy and facilitate efficient genomic development initiatives.
- Technology Segmentation: Digital solutions support sequence alignment, genome annotation, and variant analysis functions. Both cloud-based and on-premises models are adopted to meet regulatory and IT framework requirements in multidisciplinary environments.
- Deployment Models: Public, private, hybrid cloud, and on-premises deployment options offer flexibility for meeting individual organizational needs for data security, risk tolerance, and governance strategies.
- Workflow Types: Informatics platforms standardize activities beginning with data ingestion and quality control through advanced analytics and decision support, maintaining consistency and efficiency throughout project phases.
- Regions Covered: The Americas, led by the US and Canada, are at the forefront of technology uptake. Europe, the Middle East, Africa, and Asia-Pacific, including China, India, Japan, South Korea, and Australia, are rapidly expanding their market presence, supported by tailored regional policy actions and operational shifts.
- Leading Companies Profiled: Solution providers such as Illumina, Thermo Fisher Scientific, QIAGEN, Roche Diagnostics, Agilent Technologies, PerkinElmer, BGI Genomics, Bio-Rad Laboratories, DNAnexus, and Genedata enable responsive workflows and empower multidisciplinary teams.
Key Takeaways for Senior Decision-Makers
- Sequencing informatics platforms improve data transfer security, support robust project management, and help bridge gaps between research and diagnostics.
- Modern systems deliver the capability to adapt rapidly to changing compliance policies and business requirements, reducing the risk of disruptions and supporting business continuity.
- Integrated analytics enable pharmaceutical and clinical teams to boost innovation, expedite research, and maintain productivity within complex scientific pipelines.
- Standardized informatics fosters interoperability, which simplifies regulatory reporting and reduces administrative complexity for compliance-focused enterprises.
- Partnering with recognized suppliers sustains data quality, strengthens operational outcomes, and helps organizations manage risks linked to market evolution.
- A scalable informatics infrastructure is essential for achieving ongoing agility as technology frameworks and regulations continue to shift.
Tariff Impact and Supplier Adaptation
Changes to U.S. tariffs affecting sequencing-related equipment and reagents are adding new levels of complexity to procurement and supply chain management. Organizations are responding by strengthening relationships with domestic suppliers, investing in local manufacturing capabilities, and customizing service offerings to address specific regional requirements. These actions reinforce organizational resilience, control cost pressures, and help minimize risks during regulatory transitions.
Methodology & Data Sources
This market overview is based on direct interviews with senior executives, bioinformatics specialists, and regulatory authorities. Insights were cross-validated using peer-reviewed studies and independent market assessments to form a reliable basis for both strategic and operational recommendations.
Why This Report Matters
- Senior leaders gain reliable market intelligence to accelerate digital transformation and select optimal platforms for next-generation sequencing initiatives.
- Procurement and compliance professionals can leverage targeted analysis to bolster their regulatory adherence and streamline routine operations.
- Comprehensive segmentation and deployment guidance support evidence-based resource allocation and alignment with enterprise priorities.
Conclusion
Next-generation sequencing informatics is enabling new efficiencies in data management and regulatory practice. Adaptive analytics and integrated compliance functionality provide lasting support for quality, resilience, and productivity in complex digital environments.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this NGS Informatics market report include:- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Roche Diagnostics International AG
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- BGI Genomics Co., Ltd.
- Bio-Rad Laboratories, Inc.
- DNAnexus, Inc.
- Genedata AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 199 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 1.99 Billion |
| Forecasted Market Value ( USD | $ 6.28 Billion |
| Compound Annual Growth Rate | 17.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |

